Clinical Trials

Show Filters
Showing 1-10 results of 13 total
Cancer

Investigational drug for breast cancer patients with brain metastases

This trial is currently enrolling
The purpose of this study is to evaluate the safety and effectiveness of investigational drug UTD1 in combination with approved capecitabine in the treatment...
Blood Disorders|Cancer

New investigational drug for Follicular Lymphoma

This trial is currently enrolling
The purpose of this study is to see if the combination of the investigational drug epcoritamab with rituximab and lenalidomide has a better response rate and...
Cancer

Investigational drug for HER2-mutated/overexpressed/amplified cancer

This trial is currently enrolling
This study is testing whether an investigational drug will help people with advanced cancers with HER2 alterations.
Cancer

New investigational drug for treatment of Myelofibrosis

This trial is currently enrolling
This study will evaluate the safety and effectiveness of Navetemadlin combined with an FDA approved dose of Ruxolitinib. The purpose of this Phase III study...
Cancer|Neurology|Neurosurgery

New investigational drug for newly-diagnosed MGMT unmethylated glioblastoma

This trial is currently enrolling
The goal of this Phase 3 clinical trial is to compare the effectiveness of niraparib versus temozolomide (TMZ) in adult participants with newly-diagnosed,...
Cancer

New investigational drug for patients with non-small cell lung cancer

This trial is currently enrolling
This study will compare an investigational drug to standard treatment in patients with unresectable, locally advanced, or metastatic non-squamous non-small...
Cancer|Women's Health

Investigational drug for treatment of Triple-Negative Breast Cancer

This trial is currently enrolling
The purpose of this study is to evaluate the safety and effectiveness of investigational drug MK2870 in combination with other approved anti-cancer...
Cancer

New investigational drug for patients with Large B-cell Lymphoma

This trial is currently enrolling
This study will compare an investigational drug, glofitamab, in combination with standard treatment POLA-R-CHP (polatuzumab vedotin plus rituximab,...
Cancer

New investigational drug for relapsed or refractory B-cell Non-Hodgkin Lymphoma.

This trial is currently enrolling
This study will evaluate the safety and anti-cancer activity of Loncastuximab Tesirine in combination with other anti-cancer agents.
Cancer|Gastroenterology

Investigational drug for treatment of advanced solid tumors

This trial is currently enrolling
The purpose of this study is to evaluate the safety and effectiveness of the investigational drug OBI-992 with advanced solid tumors that have been treated...